You must be logged into the site to view this content.
Vous n'êtes pas connecté
Radiopharmaceutical medical imaging manufacturer Cyclopharm has revealed a possible new use for its Technegas system – for evaluating the progress of lung transplantation. The use is detailed in a US-based study which highlights the clinical utility and operational benefits of the Technegas technology compared to current US ventilation imaging radiopharmaceuticals used in lung transplant evaluation.… The post Technegas’ new use in lung transplant imaging appeared first on Australian Manufacturing Forum.
You must be logged into the site to view this content.
Consuming a high-fiber diet after undergoing stem cell transplantation could help to reduce the risk of graft-versus-host disease (GVHD) by...
Patients with acute myeloid leukaemia who have lower education levels and lower income are less likely to receive a allogeneic haematopoietic stem...
Patients with acute myeloid leukaemia who have lower education levels and lower income are less likely to receive a allogeneic haematopoietic stem...
Researchers have conducted the first study to compare lung macrophages across various lung injury models. Their findings reveal that macrophages...
Unionaire Group, a leading home appliances manufacturer, has unveiled plans to launch a state-of-the-art factory with an investment of approximately...
Two months ago in the UK, a 17-year old girl with autism took the field in her all-women team for a match in a single-sex soccer league. She noticed...